Skip to main content
. 2020 Sep 9;12(9):2565. doi: 10.3390/cancers12092565

Figure 2.

Figure 2

Therapeutic strategies for targeting EBV-associated lymphomagenesis. EBV-expressed latent proteins induce cell cycle arrest and cell apoptosis through the regulation of many crucial signaling pathways during lymphomagenesis. Specific small molecule inhibitors (italic font) that can target the key factors in these pathways are underlined.